Glenmark Specialty SA, a pharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) to sell a new version of a heartburn medicine in the United States. This medicine is called Esomeprazole Magnesium Delayed-Release Capsules, 20 mg, and it is an over-the-counter (OTC) drug, which means you can buy it without a prescription.

Esomeprazole Magnesium helps treat symptoms of gastroesophageal reflux disease (GERD), a condition where stomach acid frequently flows back into the esophagus, causing heartburn and irritation. It reduces the amount of acid produced in the stomach, providing relief from heartburn and helping to prevent damage to the esophagus. It is also used to treat other conditions related to excess stomach acid and to help heal damage to the esophagus caused by acid.

The FDA confirmed that Glenmark’s product works the same way as Nexium® 24HR, a well-known heartburn medicine made by Haleon U.S. Holdings LLC. Glenmark will sell this new product in the U.S. through its subsidiary, Glenmark Therapeutics Inc., USA.

Nexium® 24HR, the original medicine, made about $259.2 million in sales over the past year, according to market data.

Glenmark already sells 197 different products in the U.S. and is waiting for approval on 50 more. They are also looking for new partnerships to expand and improve their range of products.

Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related News